0001567619-22-016220.txt : 20220815
0001567619-22-016220.hdr.sgml : 20220815
20220815165449
ACCESSION NUMBER: 0001567619-22-016220
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20220630
FILED AS OF DATE: 20220815
DATE AS OF CHANGE: 20220815
EFFECTIVENESS DATE: 20220815
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Athyrium Capital Management, LP
CENTRAL INDEX KEY: 0001728001
IRS NUMBER: 263965190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18509
FILM NUMBER: 221166405
BUSINESS ADDRESS:
STREET 1: 505 FIFTH AVENUE, FLOOR 18
CITY: NEW YORK
STATE: NY
ZIP: 10017
BUSINESS PHONE: 212-402-6925
MAIL ADDRESS:
STREET 1: 505 FIFTH AVENUE, FLOOR 18
CITY: NEW YORK
STATE: NY
ZIP: 10017
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001728001
XXXXXXXX
06-30-2022
06-30-2022
Athyrium Capital Management, LP
505 FIFTH AVENUE, FLOOR 18
NEW YORK
NY
10017
13F HOLDINGS REPORT
028-18509
N
Andrew Hyman
Chief Operating Officer and General Counsel
212-402-6925
/s/ Andrew Hyman
New York
NY
08-15-2022
0
11
237754
false
INFORMATION TABLE
2
form13fInfoTable.xml
Biora Inc.
COM
74319F107
20899
29855847
SH
SOLE
NA
29855847
0
0
Biora Inc.
Note 7.250% 12/0
74319FAB3
65534
103500000
PRN
SOLE
NA
0
0
103500000
Amryt Pharma PLC
Sponsored ADS
03217L106
61912
8857268
SH
SOLE
NA
8857268
0
0
Societal CDMO Inc.
Com
75629F109
1751
2202420
SH
SOLE
NA
2202420
0
0
CAREMAX INC
COM CL A
14171W103
16289
4487219
SH
SOLE
NA
4487219
0
0
RVL PHARMACEUTICALS PLC
SHS
G6S41R101
11082
8148832
SH
SOLE
NA
8148832
0
0
Omeros Corp
NOTE 6.250%11/1
682143AE2
18642
21005000
PRN
SOLE
NA
0
0
21005000
Omeros Corp
NOTE 5.250% 2/1
682143AG7
20284
35150000
PRN
SOLE
NA
0
0
35150000
BridgeBio Pharma Inc.
NOTE 2.250% 2/0
10806XAD4
8393
20000000
PRN
SOLE
NA
0
0
20000000
PUMA BIOTECHNOLOGY INC
COM
74587V107
5108
1792114
SH
SOLE
NA
1792114
0
0
Paratek Pharmaceuticals Inc.
NOTE 4.750% 5/0
699374AB0
7860
9000000
SH
SOLE
NA
0
0
9000000